Peter Keller Selected Research

Peter Keller Research Topics

3	Infections 01/2019 - 06/2011
2	Neoplasms (Cancer) 05/2023 - 01/2019
1	Hepatomegaly 06/2023
1	Hemolytic Anemia 07/2021
1	Iron Overload 07/2021
1	Iron Deficiencies 01/2020
1	Fatigue 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Primary Myelofibrosis (Myelosclerosis) 01/2019
1	Endocarditis 01/2019
1	Aspergillosis 02/2017
1	Persistent Infection 04/2014
1	Communicable Diseases (Infectious Diseases) 04/2014
1	Thrombocytopenia (Thrombopenia) 01/2014
1	Hypersensitivity (Allergy) 06/2011
1	Disseminated Intravascular Coagulation 12/2009
1	Immunoglobulin Light-chain Amyloidosis 12/2009

2	Hemoglobins (Hemoglobin)IBA 07/2021 - 01/2020
1	EnzymesIBA 06/2023
1	mepazineIBA 05/2023
1	Succinic Acid (Succinate)IBA 05/2023
1	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 05/2023
1	Programmed Cell Death 1 ReceptorIBA 05/2023
1	hemoglobin MizuhoIBA 07/2021
1	IronIBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	NestinIBA 01/2019
1	mirabegronIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Sympathomimetics (Sympathomimetic Amines)IBA 01/2019
1	Reticulin (Reticular Fiber)IBA 01/2019
1	16S Ribosomal RNAIBA 01/2019
1	Isoniazid (Ftivazide)FDA LinkGeneric 07/2017
1	TAM16 compoundIBA 07/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 07/2017
1	Sodium Glutamate (Accent)IBA 02/2017
1	AzolesIBA 02/2017
1	MicroRNAs (MicroRNA)IBA 04/2014
1	Biomarkers (Surrogate Marker)IBA 04/2014
1	Edetic Acid (EDTA)FDA Link 01/2014
1	Interferon-gamma (Interferon, gamma)IBA 06/2011
1	ZincIBA 06/2011
1	Metalloproteases (Metalloproteinases)IBA 06/2011
1	AntigensIBA 06/2011
1	Tranexamic Acid (AMCA)FDA Link 12/2009

3	Therapeutics 05/2023 - 12/2009
1	Immunotherapy 05/2023